Public annual accounts

Dr. Peggy Bruynseels BV financials

Name: Dr. Peggy Bruynseels BV financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Dr. Peggy Bruynseels BV, with comparable measures and links to available source documents.

Company overview

Registry number

0882165609

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for Dr. Peggy Bruynseels BV

2025 versus 2024

Operating line: €312,165
EBITDA: €308,324
Total assets: €2,139,828
Equity: €2,101,604

EBITDA margin +98.8% · Equity ratio +98.2%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Jun 2025	€312,165	€308,324	€2,139,828	€2,101,604	-
202430 Jun 2024	€315,482	€312,075	€2,046,228	€1,971,994	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202530 Jun 2025

€312,165

€308,324

€2,139,828

€2,101,604

202430 Jun 2024

€315,482

€312,075

€2,046,228

€1,971,994